News Links
Celiac News from February 6, 2019
Gluten-free products in celiac disease: Nutritional and technological challenges and solutions. (HTML)
Read MoreLegislative and Policy News from February 6, 2019
Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients Congress holds first hearings on insulin, high drug prices My Wall Street Journal Op-Ed: Don’t Blame Drug Prices on ‘Big Pharma’
Read MorePopular Press from February 6, 2019
Rotavirus Vaccine May Protect Against Type 1 Diabetes To save his parents money, this diabetic teen cut back on his insulin Type 1 Diabetics could get new help from an old medicine Functional Insulin-Producing Cells Grown In Lab Type 1 diabetes status not associated with reading, math scores in children
Read MoreDaily Care News from February 6, 2019
Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth. Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands. (HTML | PDF) The Rate of Hyperglycemia and Ketosis With Insulin Degludec-Based Treatment Compared With Insulin Detemir in Pediatric Patients With Type 1 Diabetes: An Analysis of Data From Two Randomized Trials. Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial. Impact of Age of Onset, Puberty, and Glycemic Control Followed […]
Read MoreResearch News from February 6, 2019
Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children. Can The Eye Help Achieve Transplant Tolerance in Type 1 Diabetes? Remission phase in children diagnosed with type 1 diabetes (T1D) in years 2012-2013 in Silesia, Poland – an observational study. Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. (HTML | PDF) Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus. Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis. Incretin-based therapies for patients with type 1 diabetes: a meta-analysis. (HTML | PDF)
Read MoreResearch News from January 16, 2019
Clinically significant cognitive impairment in older adults with type 1 diabetes. Predicting Progression to Type 1 Diabetes from Ages 3 to 6 in Islet Autoantibody Positive TEDDY Children. The Clinical Case for the Integration of a Ketone Sensor as Part of a Closed Loop Insulin Pump System. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study. Metabolic effects of glucagon in humans. Free full text available in HTML and PDF formats.
Read MoreResearch News from January 9, 2019
Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
Read MoreResearch News from January 2, 2019
Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes. Extracellular hemoglobin combined with an O2 -generating material overcomes O2 limitation in the bioartificial pancreas. Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells. See also Mount Sinai Researchers Discover New Drug Cocktail That Increases Human Beta Cell Proliferation at Rapid Rates and Diabetes: New drug cocktail increases human beta cell proliferation at rapid rates. Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review. […]
Read MorePopular Press from December 26, 2018
Novartis, China’s Gan & Lee push into insulin amid diabetes epidemic. MCG researchers say most important work still ahead for Type I diabetes. The doctor will see you now — and you, and you, and you. How Novant Health CEO Carl Armato’s Type 1 diabetes changed the lives of more than 6,000 patients. Insulin cost: Taking my own advice and taking it personally. Beta Bionics Wins Readers’ Choice for Medtech Company of the Year.
Read More